Cui J - Search Results

1

Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes In Vitro.

Wen T, Gao Y, Zheng Y, Shan B, Song C, An Y, Cui J. Wen T, et al. Among authors: cui j. Curr Pharm Biotechnol. 2024;25(4):510-519. doi: 10.2174/0113892010258845231101091359. Curr Pharm Biotechnol. 2024. PMID: 37957921

2

Screening of Peptides that Specifically Binds to M3-M4 Extracellular Domain of Sodium Pump α1 Subunit and Analysis of Their Bioactivity In Vitro and In Vivo.

Wen T, Li C, Li S, Yu P, Yu X, Li L, Cui J. Wen T, et al. Among authors: cui j. Bull Exp Biol Med. 2023 Dec;176(2):275-282. doi: 10.1007/s10517-024-06008-z. Epub 2024 Jan 9. Bull Exp Biol Med. 2023. PMID: 38194073

3

Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.

Li C, Cui J, Li Y, Wang C, Li Y, Zhang L, Zhang L, Guo W, Wang J, Zhang H, Hao Y, Wang Y. Li C, et al. Among authors: cui j. Eur J Pharm Sci. 2008 Aug 7;34(4-5):333-44. doi: 10.1016/j.ejps.2008.05.006. Epub 2008 Jun 3. Eur J Pharm Sci. 2008. PMID: 18573336

4

Ni2+-mediated mitoxantrone encapsulation: improved efficacy of fast release formulation.

Cui J, Li C, Wang L, Wang C, Yang H, Li Y, Zhang L, Zhang L, Guo W, Liang M. Cui J, et al. Int J Pharm. 2009 Feb 23;368(1-2):24-30. doi: 10.1016/j.ijpharm.2008.09.045. Epub 2008 Oct 7. Int J Pharm. 2009. PMID: 18973800

5

Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?

Cui J, Li C, Wang C, Li Y, Zhang L, Zhang L, Xiu X, Li Y, Wei N. Cui J, et al. J Pharm Sci. 2011 Jul;100(7):2835-48. doi: 10.1002/jps.22496. Epub 2011 Feb 8. J Pharm Sci. 2011. PMID: 21305545

6

Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.

Li C, Cui J, Wang C, Wang J, Li Y, Zhang L, Zhang L, Guo W, Wang Y. Li C, et al. Among authors: cui j. Int J Pharm. 2008 Oct 1;362(1-2):60-6. doi: 10.1016/j.ijpharm.2008.06.008. Epub 2008 Jun 13. Int J Pharm. 2008. PMID: 18598745

7

Nigericin-mediated liposome loading of topotecan: is nigericin a potential drug release regulator?

Cui J, Li C, Wang C, Li Y, Zhang L, Zhang L, Xiu X, Li Y, Wei N. Cui J, et al. Int J Pharm. 2010 Oct 31;399(1-2):31-6. doi: 10.1016/j.ijpharm.2010.07.050. Epub 2010 Aug 1. Int J Pharm. 2010. PMID: 20678563

8

Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in L1210 ascitic tumor and exhibits dose-dependent activity saturation effect.

Li C, Zhao X, Deng C, Wang C, Wei N, Cui J. Li C, et al. Among authors: cui j. Int J Pharm. 2014 Jan 2;460(1-2):165-72. doi: 10.1016/j.ijpharm.2013.10.023. Epub 2013 Oct 20. Int J Pharm. 2014. PMID: 24148664

9

Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?

Cui J, Li C, Guo W, Li Y, Wang C, Zhang L, Zhang L, Hao Y, Wang Y. Cui J, et al. J Control Release. 2007 Apr 2;118(2):204-15. doi: 10.1016/j.jconrel.2006.12.002. Epub 2006 Dec 8. J Control Release. 2007. PMID: 17239468

10

Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase.

Cui J, Li C, Wang C, Li Y, Zhang L, Zhang L, Yang H. Cui J, et al. J Pharm Pharmacol. 2008 Dec;60(12):1651-7. doi: 10.1211/jpp/60.12.0011. J Pharm Pharmacol. 2008. PMID: 19000370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,767 results

Search Page

Filters